(April 22 20:00) Forbes.com
We think that Stryker Corp. stock (NYSE: SYK) currently is a better pick compared to its industry peer, Abbott stock (NYSE: ABT), despite it being the more expensive of the two, trading at 6.1x trailing revenues compared to 5.1x for Abbott.
You can find the original article
here